TITLE

Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China

AUTHOR(S)
Wang, Rui-jue; Lu, Lin-jie; Jin, Liang-bin; Li, Hong-yuan; Ren, Guo-sheng; Wu, Kai-nan; Liu, Sheng-chun; Kong, Ling-quan
PUB. DATE
January 2014
SOURCE
Medical Oncology;Jan2014, Vol. 31 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
93504262

 

Related Articles

  • Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus. DE HE; JING-WEN BAI; JING LIU; CAI-WEN DU; WEN-HE HUANG; GUO-JUN ZHANG // Molecular & Clinical Oncology;2015, Vol. 3 Issue 3, p607 

    Type 2 diabetes mellitus (T2DM) can increase the risk of several common cancers, including breast cancer (BC). The purpose of the present study was to investigate the clinicopathological features and prognosis of BC patients with or without T2DM. Seventy-eight patients were diagnosed with T2DM...

  • Diabetic Mastopathy: An Uncommon Complication of Diabetes Mellitus. Kirby, R. X.; Mitchell, D. I.; Williams, N. P.; Cornwall, D. A.; Cawich, S. O. // Case Reports in Surgery;2013, p1 

    Introduction. Whilst most consequences of diabetes mellitus are well recognized, breast-related complications remain obscure. The term diabetic mastopathy (DMP) attempts to describe the breast-related consequences of diabetes. Methods. We report the clinicopathologic findings in a patient with...

  • The Impact of Body Mass Index and Type 2 Diabetes on Breast Cancer: Current Therapeutic Measures of Prevention. Resta, F.; Triggiani, V.; Sabb�, C.; Licchelli, B.; Ghiyasaldin, S.; Liso, A.; Schittulli, F.; Quaranta, M.; Paradiso, A.; Tafaro, E.; Guastamacchia, E. // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Dec2004, Vol. 4 Issue 4, p327 

    Epidemiological data have suggested a possible relationship between obesity, diabetes mellitus and cancer risk, particularly breast cancer. We set out to investigate the effect of body mass index and diabetes mellitus on the presence of breast cancer in the Apulian population. We selected 1,663...

  • The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes. Chen Xin; Ding Jing; Tang Jie; Luo Wu-Xia; Qiu Meng; Liu Ji-Yan // Journal of Cancer Research & Therapeutics;Apr-Jun2015, Vol. 11 Issue 2, p295 

    Context: The insulin-like growth factor (IGF) and insulin receptors' (IR) axes play important roles in both breast cancer and diabetes mellitus. Aim: We tend to explore the expression characteristics of proteins in IGF/IR axis in breast cancer with type 2 diabetes mellitus (T2DM). Settings and...

  • GLP-1 analogues increase risk of breast cancer?  // Reactions Weekly;10/29/2016, Vol. 1625 Issue 1, p11 

    The article presents the study which examines the risk for breast cancer with Glucagon-like peptide-1 receptor agonists in women with type 2 diabetes mellitus.

  • Poster Walk IV.  // Clinical Pharmacology & Therapeutics;Feb2015 Supplement, Vol. 97, pS99 

    The article presents abstracts on medical topics which include analysis for the quality of anticoagulation meant for patients in hospitals, the effect metformin has on breast cancer patients with type 2 diabetes mellitus and risk of congenital malformations for offsprings exposed to valproic acid.

  • Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Kaplan, Muhammet; Pekkolay, Zafer; Kucukoner, Mehmet; İnal, Ali; Urakci, Zuhat; Ertugrul, Hamza; Akdogan, Recai; Firat, Ugur; Yildiz, İsmail; Isikdogan, Abdurrahman // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1576 

    It has been suggested that type 2 diabetes mellitus may affect breast cancer prognosis, possibly due to increased diabetes-related comorbidity, or direct effects of insulin resistance and/or hyperinsulinemia. The aim of this study was to determine the impact of diabetes on disease-free survival...

  • Presidential Trainee Awards.  // Clinical Pharmacology & Therapeutics;Feb2015 Supplement, Vol. 97, pS11 

    The article presents abstracts on medical topics which include an approach to identify novel biomarkers of Hydrochlorothiazide blood pressure response, effects of Metformin in breast cancer patients who have type 2 diabetes mellitus and trends in U.S. childhood vaccination practice.

  • Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers. Bezić, Joško; Šamija Projić, Ivana; Projić, Petar; Ljubković, Jelena; Zekić Tomaš, Sandra; Meljanac Salopek, Kristina; Piljić Burazer, Marina; Tomić, Snježana // Virchows Archiv;Feb2015, Vol. 466 Issue 2, p185 

    The aim of the study was to explore possible differences in DNA flow cytometric characteristics, particularly differences in distribution of DNA indices of aneuploid clones, between male and female breast cancers. We retrospectively analyzed 31 male breast cancers. Clinicopathological and DNA...

  • Diabetic Mastopathy as a Radiographically Occult Palpable Breast Mass. Thanarajasingam, Uma; Beiyun Chen; Tortorelli, Cindy L.; Jakub, James W.; Ghosh, Karthik // Case Reports in Medicine;2011, p1 

    Diabetic mastopathy is an uncommon, benign disease of the breast that can occur in women with diabetes and clinically mimic breast cancer. We describe a patient with long-standing type 1 diabetes who presented with a palpable breast mass with negative imaging findings on mammography,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics